組織再生材料のパイプラインレポート：開発段階、セグメント、地域・国、規制パス、主要企業-2022年最新版

当レポートでは、世界の組織再生材料市場について調査分析し、研究開発戦略を向上させるための重要な競合情報・分析・洞察、効果的な対抗戦略を立てて競争優位を獲得するための強力な製品ポートフォリオを持つ新興企業、開発中の重要かつ多様なタイプの組織再生材料、市場参入と市場開拓の戦略立案、最も有望なパイプラインを持つ主要企業および効果的なM&A計画、製品の現在の開発段階、領域、発売予定日の詳細な分析等に関する情報を提供しています。

目次

第1章 目次

• テーブル一覧
• 図一覧

第2章 イントロダクション

• 組織再生材料の概要

第3章：開発中の製品

• 組織再生材料：開発段階別パイプライン製品
• 組織再生材料：地域別パイプライン製品
• 組織再生材料：規制パス別パイプライン製品
• 組織再生材料：承認予定日別パイプライン製品
• 組織再生材料：進行中の臨床試験

第4章：組織再生材料：企業が開発中のパイプライン製品

• 組織再生材料企業：開発段階別パイプライン製品
• 組織再生材料：開発段階別パイプライン製品

第5章 組織再生材料企業と製品概要

• Advanced Biotech Products Pvt Ltd 企業概要
• Colorado Therapeutics, LLC 企業概要
• credentis AG 企業概要
• Histocell SL 企業概要
• Indian Institute of Technology Bombay 企業概要
• Maxigen Biotech Inc 企業概要
• Medtronic Plc 企業概要
• Nobel Biocare Services AG 企業概要
• Novatissue SAS 企業概要
• Orthocell Ltd 企業概要
• Orthorebirth Co Ltd 企業概要
• Polytechnic University of Catalonia 企業概要
• Straumann Holding AG 企業概要
• SurgaColl Technologies Ltd 企業概要
• SweetBio, Inc. 企業概要
• Tetratherix Pty Ltd 企業概要
• Tigran Technologies AB 企業概要

第6章 組織再生材料：最近の開発

第7章 付録

• 調査手法
• GlobalDataについて
• お問い合わせ
• 免責事項

List of Tables

List of Tables

• Tissue Regenerative Materials - Pipeline Products by Stage of Development
• Tissue Regenerative Materials - Pipeline Products by Territory
• Tissue Regenerative Materials - Pipeline Products by Regulatory Path
• Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
• Tissue Regenerative Materials - Ongoing Clinical Trials
• Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
• Tissue Regenerative Materials - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Tissue Regenerative Materials - Pipeline Products by Stage of Development
• Tissue Regenerative Materials - Pipeline Products by Territory
• Tissue Regenerative Materials - Pipeline Products by Regulatory Path
• Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
• Tissue Regenerative Materials - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Tissue Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Tissue Regenerative Materials pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue Regenerative Material is a biomaterial component which facilitates regeneration of lost periodontal hard and soft tissue.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Tissue Regenerative Materials under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Tissue Regenerative Materials and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Tissue Regenerative Materials under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Tissue Regenerative Materials Overview

3 Products under Development

• 3.1 Tissue Regenerative Materials - Pipeline Products by Stage of Development
• 3.2 Tissue Regenerative Materials - Pipeline Products by Territory
• 3.3 Tissue Regenerative Materials - Pipeline Products by Regulatory Path
• 3.4 Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
• 3.5 Tissue Regenerative Materials - Ongoing Clinical Trials

4 Tissue Regenerative Materials - Pipeline Products under Development by Companies

• 4.1 Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
• 4.2 Tissue Regenerative Materials - Pipeline Products by Stage of Development

5 Tissue Regenerative Materials Companies and Product Overview

• 5.1 Advanced Biotech Products Pvt Ltd Company Overview
• 5.2 Colorado Therapeutics, LLC Company Overview
• 5.3 credentis AG Company Overview
• 5.4 Histocell SL Company Overview
• 5.5 Indian Institute of Technology Bombay Company Overview
• 5.6 Maxigen Biotech Inc Company Overview
• 5.7 Medtronic Plc Company Overview
• 5.8 Nobel Biocare Services AG Company Overview
• 5.9 Novatissue SAS Company Overview
• 5.10 Orthocell Ltd Company Overview
• 5.11 Orthorebirth Co Ltd Company Overview
• 5.12 Polytechnic University of Catalonia Company Overview
• 5.13 Straumann Holding AG Company Overview
• 5.14 SurgaColl Technologies Ltd Company Overview
• 5.15 SweetBio, Inc. Company Overview
• 5.16 Tetratherix Pty Ltd Company Overview
• 5.17 Tigran Technologies AB Company Overview

6 Tissue Regenerative Materials- Recent Developments

• 6.1 May 26, 2022: CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results
• 6.2 Apr 13, 2022: CollPlant To Present at the Aesthetics Innovation Summit 2022
• 6.3 Mar 24, 2022: CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results
• 6.4 Feb 15, 2022: Straumann Group reports revenue exceeding CHF 2 billion
• 6.5 Feb 04, 2022: Straumann Group announces invitation for 2021 full-year financial results webcast
• 6.6 Jan 25, 2022: Medprin Regenerative Medical Technologies Announces on the resignation of the company's director and board secretary
• 6.7 Jan 07, 2022: Collagen Matrix Names Tony Orsini Chief Operating Officer
• 6.8 Dec 21, 2021: Maipu Medical Announcement on Appointment of Deputy General Manager of the Company
• 6.9 Nov 18, 2021: CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results
• 6.10 Oct 18, 2021: Straumann Group 2021 third-quarter financial results webcast invitation
• 6.11 Aug 19, 2021: CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results
• 6.12 Jul 29, 2021: Invitation: Straumann Group 2021 half-year financial results webcast
• 6.13 Jul 15, 2021: Christian Ullrich joins Straumann Group's Executive Management Board as the new Group Chief Information Officer

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer